Literature DB >> 12173745

Novel binding of GTP to the phosphoprotein (P) of vesicular stomatitis virus.

Manjula Mathur1, Amiya K Banerjee.   

Abstract

The phosphoprotein (P) of vesicular stomatitis virus (VSV) is a subunit of the RNA polymerase (L) that transcribes the negative strand genome RNA into mRNAs both in vitro and in vivo. We have previously shown that the P protein of VSV, expressed in E. coli, is biologically inactive unless phosphorylated at specific serine residues by cellular casein kinase II (CKII). In the present study we present evidence that the P protein, in addition to being phosphorylated, binds covalently to GTP only when it is phosphorylated. Competition experiments show that ATP, ADP, GTP, and GDP can compete for the binding site(s) of GTP but not AMP, GMP, CTP, or UTP. Interestingly, once GTP is bound to P protein it cannot be displaced by unlabeled GTP. The GTP binding site has been mapped within the domain where the phosphorylation of P protein by CKII occurs. Finally, we show that phosphorylation negative P mutants P3A (P60A, P62A, P64A), P3E (P60E, P62E, P64E), and P3R (P60R, P62R, P64R) failed to bind to GTP, indicating that phosphorylation of P is indeed essential for binding to GTP. Although the precise role of binding of GTP to P is unclear, it appears that phosphorylation of P may initiate a structural change within the P protein allowing GTP to bind, thus manifesting biological function to the transcription factor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12173745      PMCID: PMC5977518          DOI: 10.3727/000000002783992488

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  31 in total

1.  The 5' terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus.

Authors:  G Abraham; D P Rhodes; A K Banerjee
Journal:  Cell       Date:  1975-05       Impact factor: 41.582

2.  Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus.

Authors:  S U Emerson; Y Yu
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

3.  Requirements and functions of vesicular stomatitis virus L and NS proteins in the transcription process in vitro.

Authors:  B P De; A K Banerjee
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The crystal structure of elongation factor EF-Tu from Thermus aquaticus in the GTP conformation.

Authors:  M Kjeldgaard; P Nissen; S Thirup; J Nyborg
Journal:  Structure       Date:  1993-09-15       Impact factor: 5.006

6.  Transcriptional activities of different phosphorylated species of NS protein purified from vesicular stomatitis virions and cytoplasm of infected cells.

Authors:  L Kingsford; S U Emerson
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

7.  Optimal replication activity of vesicular stomatitis virus RNA polymerase requires phosphorylation of a residue(s) at carboxy-terminal domain II of its accessory subunit, phosphoprotein P.

Authors:  L N Hwang; N Englund; T Das; A K Banerjee; A K Pattnaik
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Phosphorylated states of vesicular stomatitis virus P protein in vitro and in vivo.

Authors:  J L Chen; T Das; A K Banerjee
Journal:  Virology       Date:  1997-02-17       Impact factor: 3.616

9.  Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P.

Authors:  S Barik; A K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

10.  The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity.

Authors:  M R Carson; S M Travis; M J Welsh
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.